InhaleRx Limited announced the appointment of Mr. Darryl Davies as Chief Executive Officer effective immediately. Mr. Davies will step down as Executive Director of the Company from 27th September 2022. Darryl Davies joined the InhaleRx Limited board on 20th July 2021 and brings with him over 16 years' experience in psychology, harm minimisation and healthcare commercialisation.

Mr. Davies has scaled wellness device company and co-founded private medicinal cannabis service provider, Cannvalate Pty Ltd, best known for award-winning patient access programs, end-to-end distribution solutions and their specialty cannabinoid and psychedelic Clinical Research Organisation, iNGEN CRO. Mr. Davies also launched Australia's first university-partnered educational programmes for the cannabis industry and has coordinated doctor education initiatives across Australia. Darryl has global industry relationships and serves as an advisor and Director to both domestic and international public and private biotech companies.